I wouldn’t touch RAD. Assets are very early stage and undifferentiated. TLX now commercial with Illuccix in Oz and FDA 1 month away. That’s the biggest trigger for any biotech. TLX has exceptional management and board. Superb execution so far. Deep pipeline they keep topping up.
I wouldn’t touch RAD. Assets are very early stage and...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.44 |
Change
0.300(1.65%) |
Mkt cap ! $6.161B | |||
| Open | High | Low | Value | Volume |
| $18.25 | $18.46 | $17.91 | $42.70M | 2.328M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5117 | $18.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.44 | 42145 | 6 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| TLX (ASX) Chart |